Health Catalyst Capital Management is a growth equity firm established in 2015 and located in New York, New York. The firm specializes in investing in high-growth, U.S.-based healthcare information technology businesses. It focuses on several key themes within the healthcare sector, targeting companies with the potential to achieve significant enterprise value in both emerging and disrupted markets worldwide. As a Registered Investment Adviser, Health Catalyst Capital Management is dedicated to identifying and supporting innovative companies that enhance healthcare delivery through technology and technology-enabled services.
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Cylinder
Series B in 2023
Founded in 2021, Cylinder delivers personalized, clinician-backed care to those suffering from digestive issues through its virtual health platform and has helped nearly 100K members to date. Cylinder's platform offers dynamically updated content and care plans designed to improve engagement and outcomes. Members enjoy access to a dedicated care team nationwide, including health coaches, registered dietitians, and GI doctors. Cylinder’s vision is to create a world where people receive convenient, personalized, and affordable access to the quality digestive health care they need to improve their overall health. Trusted by businesses including Texas A&M University, US Foods, and more, Cylinder showcases up to 5:1 ROI and an average of 13% employee engagement. Learn more at cylinderhealth.com.
Clearsense
Series D in 2023
Clearsense, LLC is a healthcare technology company based in Jacksonville, Florida, founded in 2013. The company specializes in providing a cloud-based data platform that offers healthcare analytics and data management solutions for organizations and patients. Its platform, known as the Clearsense Data Management Platform, aggregates and manages data from various sources, facilitating real-time insights into clinical, operational, and financial metrics. By converting disparate data into a single source of truth, Clearsense enhances data maturity and optimizes analytics tools, ultimately improving decision-making and driving meaningful outcomes. The platform is designed to be secure and scalable, empowering healthcare organizations to leverage their data effectively, reduce costs, and seize new revenue opportunities.
ReferWell
Series B in 2023
ReferWell operates a cloud-based platform that addresses the challenges associated with care transitions in healthcare. By connecting providers into Virtually Integrated Networks, ReferWell enhances visibility and coordination throughout the patient journey, ensuring efficient communication among providers and payers. The platform enables healthcare organizations to guide patients toward high-quality providers, thereby improving patient compliance, reducing leakage, and closing care gaps. Additionally, ReferWell's comprehensive services streamline referrals, facilitate point-of-care appointment scheduling, and support care teams with features such as provider directory management, eConsult, and telehealth capabilities. This holistic approach not only enhances patient experiences and outcomes but also aids clients in increasing revenue and improving healthcare metrics.
Holmusk
Series B in 2023
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.
Holmusk
Venture Round in 2021
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.
PierianDx
Venture Round in 2021
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.
Click Therapeutics
Series B in 2021
Click Therapeutics, Inc. is a New York-based company that specializes in the engineering, validation, development, and commercialization of digital therapeutics aimed at addressing unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012, Click Therapeutics focuses on creating software-based medical treatments for various conditions, including smoking cessation, major depressive disorders, schizophrenia, insomnia, and chronic pain. Its innovative Digital Therapeutics™ can be utilized independently or alongside traditional biomedical treatments, enhancing patient engagement and treatment outcomes. The company's Clickometrics® adaptive data science platform personalizes user experiences to optimize results. Notably, Click's smoking cessation program has successfully launched nationwide, and its leading prescription program is currently undergoing a phase III FDA registration trial for treating Major Depressive Disorder in adults.
Ilumivu
Series A in 2021
Ilumivu, established in 2009, specializes in healthcare decision support applications that leverage the psychology of behavior change alongside real-time data from smartphones and wearables. The company is dedicated to improving patient care outcomes through just-in-time adaptive interventions tailored to individual baselines. Ilumivu's digital health platform is utilized for monitoring various health conditions, including diabetes, sleep apnea, hypertension, and chronic diseases such as Alzheimer’s and cancer. With a foundation in extensive research from over 100 leading universities and health systems, Ilumivu supports healthcare research through its software as a service (SaaS) solutions. In 2021, the company expanded its offerings by acquiring Cardiogram, a heart health app that utilizes a neural network to analyze cardiovascular data, aiding users in identifying conditions such as atrial fibrillation and hypertension. The Cardiogram app is compatible with multiple smartphone operating systems and wearable devices, boasting over 2.6 million downloads globally.
Pager
Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Clearsense
Venture Round in 2021
Clearsense, LLC is a healthcare technology company based in Jacksonville, Florida, founded in 2013. The company specializes in providing a cloud-based data platform that offers healthcare analytics and data management solutions for organizations and patients. Its platform, known as the Clearsense Data Management Platform, aggregates and manages data from various sources, facilitating real-time insights into clinical, operational, and financial metrics. By converting disparate data into a single source of truth, Clearsense enhances data maturity and optimizes analytics tools, ultimately improving decision-making and driving meaningful outcomes. The platform is designed to be secure and scalable, empowering healthcare organizations to leverage their data effectively, reduce costs, and seize new revenue opportunities.
Glooko
Series D in 2021
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Insightin Health
Series A in 2021
Insightin Health is a technology company focused on enhancing healthcare member acquisition, retention, and engagement through its personalized preventative care platform. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers the inGAGE™ platform, which integrates various determinants of health—medical, clinical, cognitive, and social—to provide tailored recommendations for individuals. This AI-driven platform facilitates data aggregation and automates campaign management, allowing healthcare organizations to deliver personalized content and actionable insights in real-time. By centralizing member activities and improving overall satisfaction, Insightin Health helps health plans enhance quality measures and reduce member churn. The company's solutions cater to a range of markets, including Medicare, Medicaid, and accountable care organizations.
Holmusk
Series A in 2020
Holmusk is a health data analytics company focused on enhancing treatment for mental health and chronic diseases. It develops a real-world evidence platform that integrates specialty behavioral health data with advanced analytics to provide evidence-based insights for treatment decisions. By leveraging artificial intelligence and data science, Holmusk accelerates research and improves patient outcomes through predictive algorithms. Its proprietary modeling platform enables clients to analyze real-world data, facilitating personalized medicine and driving data-driven approaches in healthcare. The company's mission is to expand evidence-based care for individuals managing behavioral health conditions, ultimately supporting the commercialization of new treatments.
ReferWell
Venture Round in 2020
ReferWell operates a cloud-based platform that addresses the challenges associated with care transitions in healthcare. By connecting providers into Virtually Integrated Networks, ReferWell enhances visibility and coordination throughout the patient journey, ensuring efficient communication among providers and payers. The platform enables healthcare organizations to guide patients toward high-quality providers, thereby improving patient compliance, reducing leakage, and closing care gaps. Additionally, ReferWell's comprehensive services streamline referrals, facilitate point-of-care appointment scheduling, and support care teams with features such as provider directory management, eConsult, and telehealth capabilities. This holistic approach not only enhances patient experiences and outcomes but also aids clients in increasing revenue and improving healthcare metrics.
Pager
Series B in 2020
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Risalto
Series A in 2019
Risalto Health focuses on improving the delivery of care for patients with musculoskeletal diseases through an innovative healthcare platform. By utilizing data science and a proprietary algorithm, the company connects patients, employers, and healthcare providers to ensure access to evidence-based care. This approach not only enhances patient outcomes by guiding them to the right specialists at the right time but also aims to reduce costs for both payers and patients. Through technology-enabled care and network management, Risalto Health addresses the challenges of ineffective and wasteful healthcare, promoting efficient and personalized treatment options for those embarking on their musculoskeletal care journey.
PierianDx
Series B in 2019
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.
Insightin Health
Seed Round in 2019
Insightin Health is a technology company focused on enhancing healthcare member acquisition, retention, and engagement through its personalized preventative care platform. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers the inGAGE™ platform, which integrates various determinants of health—medical, clinical, cognitive, and social—to provide tailored recommendations for individuals. This AI-driven platform facilitates data aggregation and automates campaign management, allowing healthcare organizations to deliver personalized content and actionable insights in real-time. By centralizing member activities and improving overall satisfaction, Insightin Health helps health plans enhance quality measures and reduce member churn. The company's solutions cater to a range of markets, including Medicare, Medicaid, and accountable care organizations.
Clareto
Series A in 2019
Clareto is a health information exchange company based in Richmond, Virginia, established in 2000. The company focuses on connecting the life insurance industry with patient-authorized health information, addressing the information gap between healthcare and life insurance. Clareto's technology facilitates the electronic exchange of health data by engaging health information exchanges, healthcare providers, and various data sources. This capability supports essential processes such as underwriting and claims for the life insurance sector, enhancing operational efficiency and informed decision-making.
Medal
Venture Round in 2019
Medal, Inc. is a healthcare company based in San Francisco, California, that specializes in the extraction, transportation, translation, and sharing of medical information. Founded in 2015, the company focuses on facilitating the review, coordination, referral, analysis, billing, and auditing of medical data to enhance efficiency in healthcare administration. As of July 2020, Medal operates as a subsidiary of CIOX Health, further strengthening its capabilities in the healthcare industry.
Simplifeye
Venture Round in 2019
Simplifeye, Inc. specializes in developing software solutions aimed at enhancing patient engagement and communication for medical professionals. Founded in 2014 and based in New York, the company offers a range of products designed to streamline practice management. Their flagship products include Amplify, a HIPAA-compliant web chat tool that facilitates real-time patient interaction and analytics; Connect, which supports telehealth conferencing and allows for the collection of essential patient information; and Scheduling, enabling patients to book appointments directly. By integrating these tools, Simplifeye aims to improve patient management, increase operational efficiency, and support healthcare providers in attracting and retaining patients across the retail healthcare landscape.
Risalto
Seed Round in 2018
Risalto Health focuses on improving the delivery of care for patients with musculoskeletal diseases through an innovative healthcare platform. By utilizing data science and a proprietary algorithm, the company connects patients, employers, and healthcare providers to ensure access to evidence-based care. This approach not only enhances patient outcomes by guiding them to the right specialists at the right time but also aims to reduce costs for both payers and patients. Through technology-enabled care and network management, Risalto Health addresses the challenges of ineffective and wasteful healthcare, promoting efficient and personalized treatment options for those embarking on their musculoskeletal care journey.
Insightin Health
Seed Round in 2018
Insightin Health is a technology company focused on enhancing healthcare member acquisition, retention, and engagement through its personalized preventative care platform. Founded in 2016 and headquartered in Gaithersburg, Maryland, with an additional office in Pittsburgh, the company offers the inGAGE™ platform, which integrates various determinants of health—medical, clinical, cognitive, and social—to provide tailored recommendations for individuals. This AI-driven platform facilitates data aggregation and automates campaign management, allowing healthcare organizations to deliver personalized content and actionable insights in real-time. By centralizing member activities and improving overall satisfaction, Insightin Health helps health plans enhance quality measures and reduce member churn. The company's solutions cater to a range of markets, including Medicare, Medicaid, and accountable care organizations.
Cardiogram
Venture Round in 2018
Cardiogram, Inc., established in 2015 and based in San Francisco, California, specializes in developing wearable devices and applications to monitor and analyze heart health. The company's technology enables users to track heart rate measurements, providing insights into how their heart responds during workouts and how various factors such as stress, diet, and exercise affect their resting heart rate. The application supports cardio-tracking for devices like the Apple Watch and Android Wear, allowing users to detect heartbeats, monitor sleep, and maintain fitness. By enabling users to visualize and share their heart rate data, Cardiogram aims to help prevent serious heart-related issues such as strokes.
BetterDoctor
Series B in 2017
BetterDoctor, Inc. is a company based in San Francisco, California, that specializes in developing web and mobile applications to assist users in finding healthcare providers. Founded in 2011, BetterDoctor allows users to specify the type of doctor they need and select their insurance plan to view a list of verified healthcare professionals. The company's platform provides accurate provider data to health plans, health systems, and various organizations through its API, facilitating the search for doctors and improving healthcare access. BetterDoctor's services have reached millions of users, powering numerous health plans and companies by enhancing the transparency and reliability of doctor data. As of June 2018, BetterDoctor operates as a subsidiary of Quest Analytics, L.L.C.
ReferWell
Private Equity Round in 2016
ReferWell operates a cloud-based platform that addresses the challenges associated with care transitions in healthcare. By connecting providers into Virtually Integrated Networks, ReferWell enhances visibility and coordination throughout the patient journey, ensuring efficient communication among providers and payers. The platform enables healthcare organizations to guide patients toward high-quality providers, thereby improving patient compliance, reducing leakage, and closing care gaps. Additionally, ReferWell's comprehensive services streamline referrals, facilitate point-of-care appointment scheduling, and support care teams with features such as provider directory management, eConsult, and telehealth capabilities. This holistic approach not only enhances patient experiences and outcomes but also aids clients in increasing revenue and improving healthcare metrics.
PierianDx
Series A in 2016
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.
PierianDx
Series A in 2015
PierianDx, Inc. is a biotechnology company that specializes in developing a cloud-based genomic software solution aimed at managing, analyzing, and interpreting complex genomic tests for clinical laboratories in the United States. Founded in 2014 and headquartered in Saint Louis, Missouri, PierianDx offers its Clinical Genomicist Workstation, which streamlines the workflow for patient cases, encompassing aspects from case accessioning to final report generation and integration with electronic health records. The company's software employs artificial intelligence to enhance the efficiency of genomic sequencing processes, thereby empowering healthcare providers to better diagnose and treat patients with cancer and other complex diseases. PierianDx also provides consulting and technical services, and collaborates strategically with organizations like RTI International. Through its accredited laboratory and extensive knowledgebase, the company supports health systems, children's hospitals, comprehensive cancer centers, and commercial laboratories in delivering integrated genomic care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.